Summary of Significant Accounting Policies (Tables)

12 Months Ended

Mar. 04, 2023

Summary of Significant Accounting Policies

Schedule of revenues

	Year Ended
	March 4,		February 26,		February 27,
	2023		2022		2021
	(53 Weeks)		(52 Weeks)		(52 Weeks)
Retail Pharmacy Segment:
Pharmacy sales	$	12,582,593	$	12,152,491	$	10,915,442
Front-end sales		5,078,820		5,218,182		5,322,943
Other revenue		123,654		124,143		126,875
Total Retail Pharmacy Segment		17,785,067		17,494,816		16,365,260
Pharmacy Services Segment revenue		6,522,299		7,323,125		7,970,137
Intersegment elimination		(215,467)		(249,686)		(292,157)
Total revenue	$	24,091,899	$	24,568,255	$	24,043,240

Schedule of principal classes of products

	Percentage
Product Class	of Sales
Prescription drugs	71.2	%
Over-the-counter medications and personal care	10.9	%
Health and beauty aids	4.3	%
General merchandise and other	13.6	%

Schedule of disaggregation of revenue

	March 4,
	2023
In thousands	(53 Weeks)
Retail Pharmacy Segment:
Pharmacy sales	$	12,582,593
Front-end sales		5,078,820
Other revenue		123,654
Total Retail Pharmacy Segment		17,785,067
Pharmacy Services Segment		6,522,299
Intersegment elimination		(215,467)
Total revenue	$	24,091,899